Author

N. Andre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

E. Pasquier· 2 shared M. Carre· 2 shared M. Le Grand· 2 shared M.-P. Montero· 2 shared B. Mouysset· 1 shared C. Blouin· 1 shared C. Carrere· 1 shared C. Colin· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

E. Pasquier

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms

J. Ariey-Bonnet, R. Berges, M.-P. Montero, B. Mouysset, P. Piris, K. Muller, G. Pinna, T. W. Failes, G. M. Arndt, N. Baeza-Kallee, C. Colin, O. Chinot, D. Braguer, X. Morelli, N. ANDRE, , E. Pasquier

This study identifies synergistic drug combinations for glioblastoma by screening core vulnerabilities and validating them in preclinical models.

bioRxiv · Dec 14, 2022Pharmacology & Toxicology

Metronomic therapy prevents emergence of drug resistance by maintaining the dynamic of intratumor heterogeneity.

M. Bondarenko, M. Le Grand, Y. Shaked, Z. Raviv, G. Chapuisat, C. Carrere, M.-P. Montero, M. Rossi, E. Pasquier, M. Carre, N. Andre

This study shows metronomic therapy better controls tumor heterogeneity than maximum-tolerated dose by leveraging drug-sensitive clones' suppressive effect on resistant ones through paracrine mechanisms.

bioRxiv · Jan 4, 2021 · PreprintCancer Biology

Caveolae coupling of melanocytes signaling and mechanics is required for human skin pigmentation

L. Domingues, I. Hurbain, F. Gilles-Marsens, N. Andre, M. Dewulf, M. Romao, C. Viaris de Lesegno, C. Blouin, C. Guere, K. Vie, G. Raposo, C. Lamaze, C. Delevoye

This study shows that caveolae in melanocytes couple signaling from keratinocytes to mechanical changes, essential for skin pigmentation and tissue homeostasis.

bioRxiv · Jun 10, 2019Cell Biology